Ann Dermatol.  2014 Oct;26(5):584-591. 10.5021/ad.2014.26.5.584.

Efficacy of Microneedling Plus Human Stem Cell Conditioned Medium for Skin Rejuvenation: A Randomized, Controlled, Blinded Split-Face Study

• Lee HJ
• Lee EG
• Kang S
• Sung JH
• Chung HM
• Kim DH

• KMID: 2265491
• DOI: http://doi.org/10.5021/ad.2014.26.5.584

Abstract

BACKGROUND
The use of growth factors in skin rejuvenation is emerging as a novel anti-aging treatment. While the role of growth factors in wound healing is well established, their use in skin rejuvenation has only recently been to be studied and no controlled trials have been performed.
OBJECTIVE
We evaluated the anti-aging effects of secretory factors of endothelial precursor cells differentiated from human embryonic stem cells (hESC-EPC) in Asian skin.
METHODS
A total of 25 women were included in this randomized, controlled split-face study. The right and left sides of each participant's face were randomly allocated to hESC-EPC conditioned medium (CM) or saline. To enhance epidermal penetration, a 0.25-mm microneedle roller was used. Five treatment sessions were repeated at 2-week intervals.
RESULTS
Physician's global assessment of pigmentation and wrinkles after treatment revealed statistically significant effects of microneedling plus hESC-EPC CM compared to microneedling alone (p<0.05). Skin measurements by Mexameter and Visiometer also revealed statistically significant effects of microneedling plus hESC-EPC CM on both pigmentation and wrinkles (p<0.05). The only minimal adverse event was mild desquamation in one participant.
CONCLUSION
Secretory factors of hESC-EPC improve the signs of skin aging and could be a potential option for skin rejuvenation.

Keyword

Aging; Conditioned culture media; Embryonic stem cell; Microneedling; Rejuvenation; Skin aging

MeSH Terms

Aging
Asian Continental Ancestry Group
Culture Media, Conditioned*
Embryonic Stem Cells
Female
Humans
Intercellular Signaling Peptides and Proteins
Pigmentation
Rejuvenation*
Skin Aging
Skin*
Stem Cells*
Wound Healing
Culture Media, Conditioned
Intercellular Signaling Peptides and Proteins

Figure

• 

  Fig. 1 Transdermal penetration of human embryonic stem cell-derived endothelial precursor cell (hESC-EPC) conditioned medium (CM). (A~C) microneedling alone (control); (D~F) microneedling plus hESC-EPC CM. Proteins in hESC-EPC CM labeled with Alexa Fluor 488 (green color) are visible in both the epidermis and dermis. Scale bar=200 µm.

• 

  Fig. 2 Photographs at baseline and after 5 treatments. Clinical photos showed greater improvements of wrinkles and dilated pores following microneedling with human embryonic stem cell-derived endothelial precursor cell conditioned medium (A, baseline; B, after 5 treatments) than microneedling alone (C, baseline; D, after 5 treatments).

• 

  Fig. 3 Photographs focusing on the periorbital areas at baseline and after 5 treatments. Periorbital wrinkles exhibited greater improvements following microneedling with human embryonic stem cell-derived endothelial precursor cell conditioned medium (A, baseline; B, after 5 treatments) than microneedling alone (C, baseline; D, after 5 treatments).

• 

  Fig. 4 Objective non-invasive skin measurements. (A) Pigmentation; (B) erythema; (C, D) wrinkles. R2: maximum roughness (C); R3: average roughness (D). *p<0.05, post-treatment comparison between microneedling alone and microneedling plus human embryonic stem cell-derived endothelial precursor cell (hESC-EPC) conditioned medium (CM); **p<0.05, pre- and post-treatment in microneedling plus hESC-EPC CM.

Reference

1. Cho SW, Moon SH, Lee SH, Kang SW, Kim J, Lim JM, et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation. 2007; 116:2409–2419.

2. Lee MJ, Kim J, Lee KI, Shin JM, Chae JI, Chung HM. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy. 2011; 13:165–178.

3. Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003; 5:25–34.

4. Kim WS, Park SH, Ahn SJ, Kim HK, Park JS, Lee GY, et al. Whitening effect of adipose-derived stem cells: a critical role of TGF-beta 1. Biol Pharm Bull. 2008; 31:606–610.

5. Seo KY, Kim DH, Lee SE, Yoon MS, Lee HJ. Skin rejuvenation by microneedle fractional radiofrequency and a human stem cell conditioned medium in Asian skin: a randomized controlled investigator blinded split-face study. J Cosmet Laser Ther. 2013; 15:25–33.

6. Kim WS, Park BS, Park SH, Kim HK, Sung JH. Antiwrinkle effect of adipose-derived stem cell: activation of dermal fibroblast by secretory factors. J Dermatol Sci. 2009; 53:96–102.

7. Park BS, Jang KA, Sung JH, Park JS, Kwon YH, Kim KJ, et al. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg. 2008; 34:1323–1326.

8. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000; 9:165–169.

9. Jakasa I, Verberk MM, Esposito M, Bos JD, Kezic S. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol. 2007; 127:129–134.

10. Kim J, Moon SH, Lee MJ, Oh IR, Shin JM, Park SJ, et al. Optimized condition to culture of endothelial precursor cells derived from human embryonic stem cells. TERM. 2008; 5:476–473.

11. Cha J, Falanga V. Stem cells in cutaneous wound healing. Clin Dermatol. 2007; 25:73–78.

12. Wu Y, Wang J, Scott PG, Tredget EE. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007; 15:Suppl 1. S18–S26.

13. Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004; 22:812–822.

14. Kim WS, Park BS, Sung JH. Protective role of adipose-derived stem cells and their soluble factors in photoaging. Arch Dermatol Res. 2009; 301:329–336.

15. Ciotti SN, Weiner N. Follicular liposomal delivery systems. J Liposome Res. 2002; 12:143–148.

16. Lademann J, Otberg N, Jacobi U, Hoffman RM, Blume-Peytavi U. Follicular penetration and targeting. J Investig Dermatol Symp Proc. 2005; 10:301–303.

17. Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine. 2006; 24:6110–6119.

18. Aust MC, Fernandes D, Kolokythas P, Kaplan HM, Vogt PM. Percutaneous collagen induction therapy: an alternative treatment for scars, wrinkles, and skin laxity. Plast Reconstr Surg. 2008; 121:1421–1429.

19. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998; 87:922–925.